361370-27-6

Basic information

• Product Name: 4-Azido-1H-pyrrolo[2,3-b]pyridine
• Synonyms: 4-Azido-1H-pyrrolo[2,3-b]pyridine;4-Azido-7-azaindole ;1H-Pyrrolo[2,3-b]pyridine, 4-azido-
• CAS NO: 361370-27-6
• Molecular Formula: C₇H₅N₅
• Molecular Weight: 159.1481
• Mol File: 361370-27-6.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-Azido-1H-pyrrolo[2,3-b]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Azido-1H-pyrrolo[2,3-b]pyridine(361370-27-6)
• EPA Substance Registry System: 4-Azido-1H-pyrrolo[2,3-b]pyridine(361370-27-6)

Safety Data

• Hazardous Substances Data: 361370-27-6(Hazardous Substances Data)

Upstream product

• 55052-28-3 4-chloro-7-azaindole 

Relevant articles and documents

NUCLEOSIDE ANALOGUES FOR THE TREATMENT OF PARASITIC INFECTIONS

The present invention relates to novel nucleoside analogues and compositions containing said nucleoside analogues. Moreover, the present invention provides processes for the preparation of the disclosed compounds, as well as methods of using them, for instance as a medicine, in particular for the diagnosis, prevention and/or treatment of parasitic infections, more specifically for use in the diagnosis, prevention and/or treatment of a Trypanosoma infection.

Novel Azole fused pyridinyl urea derivatives or pharmaceutically acceptable salts thereof, preparation method therof and pharmaceutical composition for use in preventing or treating Urotensin-Ⅱ receptor activity related diseases containing the same as an active ingredient

The present invention refers to novel azole-junction pyridyl urea derivatives or a pharmaceutically acceptable salt, including effect because of having immunosuppressive effect and manufacturing method thereof urotensin-II receptor activity associated for preventing or treating disease is directed to pharmaceutical composition. Azole the present invention according to a urea derivatives pyridyl-junction U-II receptor antagonist to may be based on congestive heart failure, heart ischemia, myocardial infarction, heart hyperplasia, cardiac fibrosis, coronary artery disease, arteriosclerosis, hypertension, asthma, renal failure, diabetes, vascular inflammatory, neurodegenerative diseases, stroke, pain, depression, such as psychotic and cancer-associated diseases, receptor activity U-II preventing or useful in the treatment of a, use can be made of,.